Literature DB >> 16123966

Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation.

Mical S Campbell1, David S Kotlyar, Colleen M Brensinger, James D Lewis, Kirti Shetty, Roy D Bloom, James F Markmann, Kim M Olthoff, Abraham Shaked, K Rajender Reddy.   

Abstract

In patients with recent onset renal insufficiency, the decision to perform combined kidney/liver transplantation (CKLT) vs. orthotopic liver transplantation alone (OLTa) can be difficult. We hypothesized that duration of renal dysfunction may correlate with creatinine elevation after liver transplantation. We retrospectively identified 69 liver transplantation patients with pretransplantation creatinine > or =1.5 mg/dL (53 OLTa, 13 CKLT). Variables analyzed were presence of hepatorenal syndrome, creatinine, Model for End-Stage Liver Disease score, albumin, age, race, gender, cause of liver disease, diabetes mellitus, hypertension, and history of ascites, spontaneous bacterial peritonitis, variceal bleeding, hepatic encephalopathy, renal replacement therapy (RRT), and transjugular intrahepatic portosystemic shunting. Duration of pretransplantation renal dysfunction was predictive of 6- and 12-month creatinine post-OLTa. Area under the receiver operating characteristic (ROC) curve for prediction of 12-month renal insufficiency by renal dysfunction duration was 0.71; optimal duration cutoff was 3.6 weeks. We applied a multivariable model, derived from OLTa patients, to CKLT subjects with definite or possible hepatorenal syndrome. Predicted 12-month creatinine without renal transplantation was >2.0 mg/dL for each patient. CKLT patients as opposed to OLTa patients had longer duration of renal dysfunction (median, 18.1 vs. 2.7 weeks, P < 0.001), higher creatinine (median 4.0 versus 1.7 mg/dL, P < 0.001), and higher rate of pretransplantation RRT (62% vs. 7%, P < 0.001). Adjusting for baseline characteristics, CKLT patients had lower creatinine than OLTa patients at 6 months (P =0.15) and 12 months (P =0.01) after transplantation. In conclusion, duration, but not cause, of renal dysfunction predicts renal outcome in OLTa recipients. Prospective studies may use duration of renal dysfunction to help identify CKLT candidates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123966     DOI: 10.1002/lt.20445

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  33 in total

Review 1.  Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.

Authors:  Pratima Sharma; Khurram Bari
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

2.  The impact of MELD allocation on simultaneous liver-kidney transplantation.

Authors:  Julie A Thompson; John R Lake
Journal:  Curr Gastroenterol Rep       Date:  2009-02

3.  Impact of MELD-based allocation on end-stage renal disease after liver transplantation.

Authors:  P Sharma; D E Schaubel; M K Guidinger; N P Goodrich; A O Ojo; R M Merion
Journal:  Am J Transplant       Date:  2011-08-22       Impact factor: 8.086

4.  End-stage kidney disease after pediatric nonrenal solid organ transplantation.

Authors:  Rebecca L Ruebner; Peter P Reese; Michelle R Denburg; Peter L Abt; Susan L Furth
Journal:  Pediatrics       Date:  2013-10-14       Impact factor: 7.124

Review 5.  Outcomes of liver transplantation in patients with hepatorenal syndrome.

Authors:  Rohan M Modi; Nishi Patel; Sherif N Metwally; Khalid Mumtaz
Journal:  World J Hepatol       Date:  2016-08-28

6.  Risk factors for end-stage kidney disease after pediatric liver transplantation.

Authors:  R L Ruebner; P P Reese; M R Denburg; E B Rand; P L Abt; S L Furth
Journal:  Am J Transplant       Date:  2012-09-20       Impact factor: 8.086

7.  Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies.

Authors:  Yaojen Chang; Lorenzo Gallon; Kirti Shetty; Yuchia Chang; Colleen Jay; Josh Levitsky; Bing Ho; Talia Baker; Daniela Ladner; John Friedewald; Michael Abecassis; Gordon Hazen; Anton I Skaro
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

8.  Risk factors for acute kidney injury following orthotopic liver transplantation: the impact of changes in renal function while patients await transplantation.

Authors:  Jose I Iglesias; John A DePalma; Jerrold S Levine
Journal:  BMC Nephrol       Date:  2010-11-08       Impact factor: 2.388

9.  Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study.

Authors:  Andreas A Schnitzbauer; Marcus N Scherer; Justine Rochon; Johannes Sothmann; Stefan A Farkas; Martin Loss; Edward K Geissler; Aiman Obed; Hans J Schlitt
Journal:  BMC Nephrol       Date:  2010-09-14       Impact factor: 2.388

10.  Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone.

Authors:  Pratima Sharma; Nathan P Goodrich; Min Zhang; Mary K Guidinger; Douglas E Schaubel; Robert M Merion
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.